SUPREFACT DEPOT 2 MONTHS 6.3 MG
BUSERELIN (BUSERELIN ACETATE) : 6.3 MG · DIN 02228955 · CHEPLAPHARM ARZNEIMITTEL GMBH
Health Canada status: DORMANT
What is SUPREFACT DEPOT 2 MONTHS?
SUPREFACT DEPOT 2 MONTHS 6.3 MG contains BUSERELIN (BUSERELIN ACETATE) : 6.3 MG. It is listed in the Health Canada Drug Product Database under DIN 02228955, held by CHEPLAPHARM ARZNEIMITTEL GMBH, supplied as IMPLANT for SUBCUTANEOUS administration. Health Canada currently lists it as dormant, status dated 01-Nov-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is SUPREFACT DEPOT 2 MONTHS used for?
SUPREFACT DEPOT 2 months and SUPREFACT DEPOT 3 months are indicated for the palliative treatment of patients with hormone-dependent advanced carcinoma of the prostate gland (Stage D).
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02228955 |
|---|---|
| Brand name | SUPREFACT DEPOT 2 MONTHS |
| Generic / active ingredient | BUSERELIN (BUSERELIN ACETATE) : 6.3 MG |
| Manufacturer | CHEPLAPHARM ARZNEIMITTEL GMBH |
| Strength | 6.3 MG |
| Dosage form | IMPLANT |
| Route of administration | SUBCUTANEOUS |
| Schedule | Prescription |
| ATC code | L02AE01 BUSERELIN |
| AHFS class | 10:00.00 |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 01-Nov-2025 |
| Original market date | 1997-02-10 00:00:00 |
How is it stored and handled?
Store the intact package between 15 °C-30 °C. PROTECT FROM EXCESSIVE HEAT and do not use beyond the expiration date printed on the container label.
How is it supplied?
SUPREFACT DEPOT 2 months or SUPREFACT DEPOT 3 months is packaged in a sterile ready-to-use disposable applicator with an integrated safety engineered needle (internal needle diameter of 1.4 mm) for subcutaneous injection. Each carton is supplied with one sterile foil bag containing one applicator pre-filled with one implant dose SUPREFACT DEPOT 2 months consists of two identical rods, while SUPREFACT DEPOT 3 months consists of three identical rods.
What can be used instead?
Other Canadian products sharing ATC code L02AE01 BUSERELIN. 1 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| SUPREFACT | 1 MG | SOLUTION | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED | DIN 02225166 |
| SUPREFACT | 100 MCG | SOLUTION | CHEPLAPHARM ARZNEIMITTEL GMBH | CANCELLED POST MARKET | DIN 02225158 |
| SUPREFACT DEPOT 3 MONTHS | 9.45 MG | IMPLANT | CHEPLAPHARM ARZNEIMITTEL GMBH | DORMANT | DIN 02240749 |
| SUPREFACT INJ 1MG/ML | 1 MG | LIQUID | HOECHST CANADA INC. | CANCELLED POST MARKET | DIN 00680028 |
| SUPREFACT INTRANASAL SOLUTION 1MG/ML | 1 MG | SPRAY | HOECHST CANADA INC. | CANCELLED POST MARKET | DIN 00680036 |
| SUPREFACT LIQ 1MG/ML | 1 MG | LIQUID | HOECHST ROUSSEL CANADA INC. | CANCELLED POST MARKET | DIN 01989669 |
Who else supplies BUSERELIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BUSERELIN appears in 10 registered pack listings across 6 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.